Skip to main content
NVDA+0.39%AAPL+1.90%GOOGL+2.05%MSFT+0.67%AMZN+1.83%TSM+1.19%SPCX+0.99%AVGO+1.16%META+0.66%TSLA+0.44%SKHY+1.40%MU-0.27%BRK-B+0.48%LLY-0.39%JPM+1.01%WMT+1.10%AMD+2.55%V+1.12%XOM+0.06%ASMLa+0.26%JNJ-0.29%INTC+3.14%MA+1.04%0700.HK+0.66%1398.HK0.00%ABBV+1.05%BAC+0.70%CSCO+4.08%ORCL-0.67%CVX+0.44%COST+0.23%KO+0.71%CAT+2.20%LRCX+1.07%DELL+10.43%AP2d+1.32%AMAT+1.65%HSBA.L+1.31%0005.HK-0.85%PG+1.46%UNH-2.55%MS+0.83%GE+0.61%3988.HK+1.34%1816.HK+0.46%NFLX+1.56%0857.HK-1.09%HD+1.23%GS+1.07%PM+1.65%NZDJPY-2.69%CHFJPY-2.41%AUDJPY-2.03%CADJPY-1.83%EURJPY-1.76%USDJPY-1.64%GBPJPY-1.56%GBPNZD+1.15%NZDUSD-1.09%EURNZD+0.97%NZDCAD-0.88%GBPCHF+0.85%USDCHF+0.79%AUDNZD+0.69%EURCHF+0.65%NOKJPY-0.63%CADCHF+0.56%PLNJPY-0.54%EURZAR-0.54%GBPAUD+0.46%CHFSGD-0.43%USDZAR-0.43%SGDJPY-0.42%GBPTRY+0.41%USDTHB+0.41%AUDUSD-0.40%AUDCHF+0.38%AUDNOK+0.37%AUDDKK+0.34%USDTRY+0.33%GBPHKD+0.32%GBPZAR-0.32%NZDCHF-0.31%NZDSGD+0.29%GBPMXN-0.28%EURAUD+0.28%GBPCAD+0.26%AUDCAD-0.23%CHFNOK-0.22%CHFSEK-0.21%USDCAD+0.21%EURCNH-0.20%NZDMXN+0.20%EURGBP-0.19%EURSGD-0.18%AUDSGD+0.17%USDILS+0.16%USDSEK+0.14%USDMXN-0.14%USDNOK+0.13%EURUSD-0.13%USDDKK+0.09%EURHKD-0.09%GBPUSD+0.08%EURCAD+0.07%USDSGD-0.07%EURPLN-0.06%USDPLN+0.05%EURSEK+0.04%GBPSGD+0.04%USDCOP-0.04%EURNOK+0.04%USDHKD+0.03%EURCZK-0.02%EURDKK-0.01%USDCNH0.00%UKOIL-4.25%USOIL-4.02%COTTON-2.34%W1-1.93%S1-1.85%GAGUSD+1.13%XAGUSD+1.12%XPTUSD+0.76%GAUUSD+0.72%XAUUSD+0.72%XNGUSD-0.43%HG1+0.31%BTCUSD+0.77%ETHUSD+4.22%USDTUSD+0.01%XRPUSD+1.72%SOLUSD+2.56%TRXUSDT-0.99%ZECUSDT+8.74%DOGEUSD+1.82%XMRUSDT+0.86%LINKUSD+1.46%XLMUSD+2.14%BCHUSDT+1.91%LTCUSD+2.48%UNIUSD+1.70%TONUSD+27.68%HBARUSDT-0.72%SUIUSD-0.02%TAOUSDT+0.01%AAVEUSD+3.10%DOTUSDT-4.27%ICPUSDT-1.70%ONDOUSDT+3.07%WLDUSDT+1.76%ARBUSDT+1.72%ATOMUSDT-7.67%JUPUSDT+7.92%INJUSDT-2.23%STXUSDT+0.08%FETUSDT+3.89%TIAUSDT-2.12%PYTHUSDT+0.83%SEIUSDT+0.56%IMXUSDT+1.66%WIFUSDT+0.74%GRTUSDT-0.30%OPUSDT+1.78%POLUSDT+4.21%IOTAUSDT-0.75%AXSUSDT+2.41%FARTCOINUSDT+3.69%EOSUSDT-0.95%DYDXUSDT+1.45%ORDIUSDT+0.13%GALAUSDT+0.30%NOTUSDT+3.12%RONINUSDT+1.10%NVDA+0.39%AAPL+1.90%GOOGL+2.05%MSFT+0.67%AMZN+1.83%TSM+1.19%SPCX+0.99%AVGO+1.16%META+0.66%TSLA+0.44%SKHY+1.40%MU-0.27%BRK-B+0.48%LLY-0.39%JPM+1.01%WMT+1.10%AMD+2.55%V+1.12%XOM+0.06%ASMLa+0.26%JNJ-0.29%INTC+3.14%MA+1.04%0700.HK+0.66%1398.HK0.00%ABBV+1.05%BAC+0.70%CSCO+4.08%ORCL-0.67%CVX+0.44%COST+0.23%KO+0.71%CAT+2.20%LRCX+1.07%DELL+10.43%AP2d+1.32%AMAT+1.65%HSBA.L+1.31%0005.HK-0.85%PG+1.46%UNH-2.55%MS+0.83%GE+0.61%3988.HK+1.34%1816.HK+0.46%NFLX+1.56%0857.HK-1.09%HD+1.23%GS+1.07%PM+1.65%NZDJPY-2.69%CHFJPY-2.41%AUDJPY-2.03%CADJPY-1.83%EURJPY-1.76%USDJPY-1.64%GBPJPY-1.56%GBPNZD+1.15%NZDUSD-1.09%EURNZD+0.97%NZDCAD-0.88%GBPCHF+0.85%USDCHF+0.79%AUDNZD+0.69%EURCHF+0.65%NOKJPY-0.63%CADCHF+0.56%PLNJPY-0.54%EURZAR-0.54%GBPAUD+0.46%CHFSGD-0.43%USDZAR-0.43%SGDJPY-0.42%GBPTRY+0.41%USDTHB+0.41%AUDUSD-0.40%AUDCHF+0.38%AUDNOK+0.37%AUDDKK+0.34%USDTRY+0.33%GBPHKD+0.32%GBPZAR-0.32%NZDCHF-0.31%NZDSGD+0.29%GBPMXN-0.28%EURAUD+0.28%GBPCAD+0.26%AUDCAD-0.23%CHFNOK-0.22%CHFSEK-0.21%USDCAD+0.21%EURCNH-0.20%NZDMXN+0.20%EURGBP-0.19%EURSGD-0.18%AUDSGD+0.17%USDILS+0.16%USDSEK+0.14%USDMXN-0.14%USDNOK+0.13%EURUSD-0.13%USDDKK+0.09%EURHKD-0.09%GBPUSD+0.08%EURCAD+0.07%USDSGD-0.07%EURPLN-0.06%USDPLN+0.05%EURSEK+0.04%GBPSGD+0.04%USDCOP-0.04%EURNOK+0.04%USDHKD+0.03%EURCZK-0.02%EURDKK-0.01%USDCNH0.00%UKOIL-4.25%USOIL-4.02%COTTON-2.34%W1-1.93%S1-1.85%GAGUSD+1.13%XAGUSD+1.12%XPTUSD+0.76%GAUUSD+0.72%XAUUSD+0.72%XNGUSD-0.43%HG1+0.31%BTCUSD+0.77%ETHUSD+4.22%USDTUSD+0.01%XRPUSD+1.72%SOLUSD+2.56%TRXUSDT-0.99%ZECUSDT+8.74%DOGEUSD+1.82%XMRUSDT+0.86%LINKUSD+1.46%XLMUSD+2.14%BCHUSDT+1.91%LTCUSD+2.48%UNIUSD+1.70%TONUSD+27.68%HBARUSDT-0.72%SUIUSD-0.02%TAOUSDT+0.01%AAVEUSD+3.10%DOTUSDT-4.27%ICPUSDT-1.70%ONDOUSDT+3.07%WLDUSDT+1.76%ARBUSDT+1.72%ATOMUSDT-7.67%JUPUSDT+7.92%INJUSDT-2.23%STXUSDT+0.08%FETUSDT+3.89%TIAUSDT-2.12%PYTHUSDT+0.83%SEIUSDT+0.56%IMXUSDT+1.66%WIFUSDT+0.74%GRTUSDT-0.30%OPUSDT+1.78%POLUSDT+4.21%IOTAUSDT-0.75%AXSUSDT+2.41%FARTCOINUSDT+3.69%EOSUSDT-0.95%DYDXUSDT+1.45%ORDIUSDT+0.13%GALAUSDT+0.30%NOTUSDT+3.12%RONINUSDT+1.10%
IP

Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ • Healthcare

$3.97
-$0.1 (-2.5%)
Market open

Last close at September 10, 2026 at 20:00 UTC

Open$4.03
Previous Close$3.97
Day Range$3.94 - $4.05
Avg. Volume (3M)1.5M
Market Cap$659.3M
P/E Ratio5.0
52 Week Range
$1.23$5.78
Next EarningsIn 59 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$113M100%
Gross Profitminus cost of goods$113M100%
Operating Incomeminus R&D and overhead$79.3M70%
Net Incomeminus taxes and the rest$51.2M45%

In plain terms: out of every $100 in revenue, Ironwood Pharmaceuticals, Inc. keeps $45 as net profit.

Fundamentals & Financials

Revenue (TTM)
$389.3M
Net Income (TTM)
$129.8M
EPS (TTM)
$0.8
ROA (TTM)
45.55%
Current Ratio
6.06

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-150.0%Q1 2026-$0.01
+242.9%Q2 2026$0.24
-3.1%Q3 2026$0.31
Next

Nov 9

in 59 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. develops and commercializes medicines for gastrointestinal conditions and related disorders, operating in the healthcare sector as a specialty drug maker listed on NASDAQ as IRWD. Its business centers on linaclotide and the brands LINZESS and CONSTELLA, and it generated $296.2 million of revenue in FY2025.

Name
Ironwood Pharmaceuticals, Inc.
CEO
Thomas A. McCourt
Website
www.ironwoodpharma.com
Industry
Healthcare
Year Founded
1998
Employees
100

Today's Snapshot

AI-generated

IRWD is trading 1.1% higher at 4.01, while its sector was flat.

Trading Volume

Below 10d avg (1.4M)

495.7K

vs S&P 500 Today

Moderate Outperformance

+0.11%

Updated: September 11, 2026 at 16:45 UTC

Technical Indicators

3 Buy1 Neutral4 Sell
IRWD is trading around $4.00 while short- and medium-term moving averages sit above the price and the 200-day averages sit just below, leaving a mixed bias. Momentum readings are muted: RSI is in the mid-40s and MACD is slightly negative, while CCI is deeply negative and stochastic/Williams readings show short-term oversold conditions. Trend strength is weak with ADX near the low-teens and volatility is modest, as ATR is under five percent. Volume breadth is negative on OBV even though the intraday VWAP and pivots sit near the current price. Technical takeaway: Neutral.
All signals
  • EMA (5 indicators)$3.68 - $4.18
    Sell
  • RSI (14)44.19
    Neutral
  • Stochastic %K (14, 3, 3)10.05
    Buy
  • MACD Level (12, 26)-0.02
    Sell

Peers & Related Assets

NPCENeuroPace, Inc.
$13.87-4.3%
CGCCanopy Growth Corporation
$0.93-0.5%
BIOABioAge Labs Inc.
$8.65-5.7%
ACBAurora Cannabis Inc.
$3.69-1.2%
ALDXAldeyra The
$1.46-2.7%
SLNSilence Therapeutics plc
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.